PIR and metastatic melanoma: Activation of the JARID1B promoter was determined through the proportion of cells expressing GFP and significantly, an increase in Pirin expression in MeWO and A2058 melanoma cells led to a significant decrease in JARID1B promoter activation in both metastatic melanoma cell lines (Fig. 5b).